Comparative Pharmacokinetics of YH14659

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions
Acute Coronary Syndrome
Interventions
DRUG

YH14659

YH14659 capsule by oral

DRUG

clopidogrel & aspirin

clopidogrel tablet(75mg) + aspirin capsules(100mg) by oral

Trial Locations (1)

156-754

Yuhan Corporation, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01422109 - Comparative Pharmacokinetics of YH14659 | Biotech Hunter | Biotech Hunter